As part of LatentView’s Corporate Social Responsibility initiatives, the Digital Analytics Firm supports IMF with solutions that provide a 360-degree view of patient data
PRINCETON, N.J., July 26, 2023 /PRNewswire-PRWeb/ – – LatentView Analytics, a global digital analytics consulting and solutions firm, today announced its collaboration with the International Myeloma Foundation, the first and largest global organization focusing specifically on multiple myeloma, through LatentView’s CSR initiative to leverage data for the greater good of society and the world.
Based on data-driven insights, LatentView built a comprehensive AI-powered knowledge platform to provide each patient with a custom dashboard displaying their personal data using HIPAA-compliant voice assistance, chatbots, and QR codes for additional accessibility. Patients are able to access all of their information in one place, including a hypothetical six-month journey, and can use their dashboard as a digital touch point to help them navigate their journey with the ability to make more informed medical decisions.
We are proud to be at the forefront of using data analytics to advance the IMF’s mission and aid in the fight against multiple myeloma.
“In the current technological landscape, data has the power to shape and drive business and markets, but there is also a significant opportunity to harness data to improve the lives of individuals, communities, and the larger global population, said Krishnan Venkata, LatentView’s Chief Client Officer, “Our work with the IMF is a testament to how data can empower patients to make informed decisions for their health. We are proud to be at the forefront of using data analytics to advance the IMF’s mission and aid in the fight against multiple myeloma.”
According to the National Cancer Institute, there are an estimated 150,000 people living with myeloma in the U.S. as of 2018. With the goal of accurately measuring and reducing the time to hope for its patients in a repeatable and scalable way, the IMF is among the non-profits that have identified the ways in which leveraging data can accelerate their mission.
“Data analytics has historically been a largely underutilized resource for non-profit organizations,” said Yelak Biru, President and CEO of the IMF. “LatentView’s collaborative and patient-centric approach to understanding our needs and goals has allowed us to take advantage of both data and the massive advancements in AI and machine learning to significantly improve our patients’ quality of life. Most importantly, what they created and delivered in the form of visual dashboards has turned our data into actionable insights.”
Read more about this journey between LatentView and IMF in this Innovation & Tech Today article.
About LatentView Analytics
LatentView Analytics is a global digital analytics consulting and solutions firm that enables companies to excel in the digital world by harnessing the power of data and analytics. The company creates holistic and sustainable impact for some of the world’s largest brands, including more than 30 Fortune 500 companies in the retail, CPG, financial services, technology, media & entertainment, travel & hospitality, and industrials sectors. LatentView has been recognized as an industry leader by Gartner, Deloitte, and others for its analytics work and vibrant company culture. Founded in 2006, LatentView has a globally distributed workforce. For more information, visit https://www.latentview.com/ or follow us on LinkedIn.
About The International Myeloma Foundation
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest global foundation focusing specifically on multiple myeloma. The Foundation’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure by focusing on four key areas: research, education, support, and advocacy. The IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned InfoLine, and in 2001, established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. In 2012, the IMF launched the Black Swan Research Initiative®, a groundbreaking research project aimed at curing myeloma. The IMF can be reached at (800) 452-CURE (2873). The global website is http://www.myeloma.org.